Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis

Clinical trial NCT05089565 · COMPLETED

Trial details

NCT number: NCT05089565
Sponsor: Northwestern University
Status: COMPLETED
Study type: OBSERVATIONAL

Sarcoidosis SARS-CoV2 Infection Vaccine Response Impaired

Start date: 2021-12-01
Primary completion: 2022-12-31
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.